Find News

Filter articles

Showing 61 to 70 of 3904 results

Firm unveils UK partner and senior associate promotions

UK09-02-2023Muireann Bolger

The patent attorneys will be based in London and Birmingham.

US firm adds partner to Minnesota office

07-02-2023Muireann Bolger

New addition joins from Fish & Richardson where he was a principal for five years.

USITC to investigate potential section 337 breach in trade secrets case

China, US07-02-2023Liz Hockley

Viking alleges Chinese competitor stole information relating to metabolic disorders drug.

Deny Amgen’s ‘dangerous’ patent claims, Sanofi urges Supreme Court

US07-02-2023Liz Hockley

French pharma firm urges US court not to allow ‘monopoly’ over market | Enablement issue at centre of antibody patent case could have wide implications for pharma and life sciences industries.

Governments may have to reserve 20% of vaccines: WHO

International02-02-2023Liz Hockley

Draft WHO agreement aims at more robust and fairer response to future pandemics | 20% of tests and drugs would go to the organisation, including 10% donated.

Boston Scientific loses stent patent case in uni feud

US02-02-2023Muireann Bolger

Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.

Apple suffers another bruising in smartwatch tech clash

US31-01-2023Sarah Speight

Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.

Cigna pursues trade secrets in ‘non-competes’ dispute

US31-01-2023Muireann Bolger

Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.

Blank Rome hires new patent agent for Texas office

US26-01-2023Muireann Bolger

Blank Rome has brought in patent agent Joseph Jackson to the firm’s IP and Technology practice group in Houston.

BMS sues AstraZeneca for infringing cancer treatment drug

US26-01-2023Liz Hockley

US pharma giant says competitor’s drug Imjudo violates two patents | BMS’ blockbuster was first to use checkpoint inhibitors, says complaint.

Showing 61 to 70 of 3904 results